Evidence map›Paper›PMID 22579707›Full record

ArticleNeurobiology of disease2012

Neurological deficits in mice with profound biotinidase deficiency are associated with demylination and axonal degeneration.

Kirit Pindolia, Jieli Chen, Cisley Cardwell, Xu Cui, Michael Chopp, Barry Wolf

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Distinct inflammatory profiles in young-onset versus late-onset Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Myelin Repair: From Animal Models to Humans.Frontiers in cellular neuroscience · 2021
    Review
  7. Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kirit PindoliaDepartment of Medical Genetics, Henry Ford Hospital, Detroit, MI 48202, USA.
Jieli Chen
Cisley Cardwell
Xu Cui
Michael Chopp
Barry Wolf
Henry Ford Hospital · USHenry Ford Health System · USOakland University · US

Funding

PREDICTION OF HUMAN BRAIN INFARCTION BY MRIP01NS023393 · NINDS · HENRY FORD HOSPITAL · PI ZHANG, ZHENG GANG · 1986 to 2011
$11.0M
Neurorestorative Therapy of Stroke with StatinsR01NS047682 · NINDS · HENRY FORD HEALTH SYSTEM · PI CHEN, JIELI · 2004 to 2007
$1.0M
NINDS NIH HHS P01 NS023393NINDS NIH HHS P01 NS23393NINDS NIH HHS R01 NS047682
6 · The paper itself

Abstract

Biotinidase deficiency is an autosomal recessively inherited disorder characterized by neurological and cutaneous abnormalities. We have developed a transgenic knock-out mouse with biotinidase deficiency to better understand aspects of pathophysiology and natural history of the disorder in humans. Neurological deficits observed in symptomatic mice with biotinidase deficiency are similar to those seen in symptomatic children with the disorder. Using a battery of functional neurological assessment tests, the symptomatic mice performed poorly compared to wild-type mice. Demyelination, axonal degeneration, ventriculomegaly, and corpus callosum compression were found in the brains of untreated, symptomatic enzyme-deficient mice. With biotin treatment, the symptomatic mice improved neurologically and the white matter abnormalities resolved. These functional and anatomical findings and their reversal with biotin therapy are similar to those observed in untreated, symptomatic and treated individuals with biotinidase deficiency. The mouse with biotinidase deficiency appears to be an appropriate animal model in which to study the neurological abnormalities and the effects of treatment of the disorder.

Indexed as

Analysis of VarianceAnimalsAxonsBiotinidaseBiotinidase DeficiencyBody WeightCorpus CallosumDemyelinating DiseasesDisease Models, AnimalHydrocephalusMiceMice, Inbred C57BLMice, KnockoutMotor NeuronsMyelin SheathNerve DegenerationBiotinidase

Identifiers

PMID22579707
PMCPMC3970768
OpenAlexW2068515765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.